Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
|Title:||Chloride channel opener|
|Abstract:||Disclosed is a novel use of a prostaglandin compound as a chloride channel opener. According to the instant invention, chloride channels in a mammalian subject can be opened by a prostaglandin compound to facilitate chloride ion transportation.|
|Inventor(s):||Ueno; Ryuji (Montgomery, MD), Cuppoletti; John (Cincinnati, OH)|
|Assignee:||Sucampo AG (Zug, CH)|
|Filing Date:||Jan 18, 2006|
|Claims:||1. A compound represented by formula (IV): ##STR00013## wherein L, M and N are hydrogen, hydroxy, halogen, lower alkyl, hydroxy(lower)alkyl, or oxo, wherein at least one of L and M is a group other than hydrogen, and the five-membered ring may have one or more double bonds; R' and R'' are hydrogen, lower alkyl, aryl, alkyl- or aryl-sulfonyl, lower alkenyl or lower alkynyl; B is --CH.sub.2--CH.sub.2--, --CH.dbd.CH-- or --C.ident.C--; R.sub.1 is a saturated or unsaturated bivalent lower or medium aliphatic hydrocarbon residue, which is unsubstituted or substituted with halogen, alkyl, hydroxy, oxo, or aryloxy, and at least one carbon atom in the aliphatic hydrocarbon is optionally substituted by oxygen, nitrogen or sulfur; and Ra is a saturated or unsaturated lower or medium aliphatic hydrocarbon residue, which is unsubstituted or substituted with halogen, oxo, hydroxy, lower alkoxy, lower alkanoyloxy, cyclo(lower)alkyl, cyclo(lower)alkyloxy, aryl, or aryloxy; cyclo(lower)alkyl; cyclo(lower)alkyloxy; aryl; or aryloxy. |
2. The compound as described in claim 1, wherein said compound is 13,14-dihydro-15-keto-16,16-difluoro-PGE.sub.1 N-ethyl amide.
3. The compound as described in claim 1, wherein said compound is 13,14-dihydro-15-keto-16,16-difluoro-PGF.sub.1.alpha. N-ethyl amide.
4. The compound as described in claim 1, wherein said compound is 13,14-dihydro-15-keto-17-phenyl-18,19,20-trinor-PGF.sub.2.alpha. N-ethyl amide.
5. The compound as described in claim 1, wherein said compound is 13,14-dihydro-15-keto-20-ethyl-PGF.sub.2.alpha. N-ethyl amide.